X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TORRENT PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA TORRENT PHARMA SANOFI INDIA/
TORRENT PHARMA
 
P/E (TTM) x 32.0 58.8 54.4% View Chart
P/BV x 5.6 5.5 101.5% View Chart
Dividend Yield % 1.5 0.9 167.5%  

Financials

 SANOFI INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
TORRENT PHARMA
Mar-18
SANOFI INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs6,8401,550 441.3%   
Low Rs4,6301,144 404.9%   
Sales per share (Unadj.) Rs1,203.1354.7 339.2%  
Earnings per share (Unadj.) Rs165.340.1 412.4%  
Cash flow per share (Unadj.) Rs209.964.2 326.8%  
Dividends per share (Unadj.) Rs84.0014.00 600.0%  
Dividend yield (eoy) %1.51.0 140.9%  
Book value per share (Unadj.) Rs963.6273.1 352.8%  
Shares outstanding (eoy) m23.03169.22 13.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.8 125.5%   
Avg P/E ratio x34.733.6 103.3%  
P/CF ratio (eoy) x27.321.0 130.3%  
Price / Book Value ratio x6.04.9 120.7%  
Dividend payout %50.834.9 145.5%   
Avg Mkt Cap Rs m132,078227,897 58.0%   
No. of employees `0003.314.7 22.5%   
Total wages/salary Rs m4,06811,353 35.8%   
Avg. sales/employee Rs Th8,393.84,083.0 205.6%   
Avg. wages/employee Rs Th1,232.4772.3 159.6%   
Avg. net profit/employee Rs Th1,153.0461.3 249.9%   
INCOME DATA
Net Sales Rs m27,70860,021 46.2%  
Other income Rs m8972,988 30.0%   
Total revenues Rs m28,60563,009 45.4%   
Gross profit Rs m6,23513,493 46.2%  
Depreciation Rs m1,0274,086 25.1%   
Interest Rs m73,085 0.2%   
Profit before tax Rs m6,0989,310 65.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2922,529 90.6%   
Profit after tax Rs m3,8066,781 56.1%  
Gross profit margin %22.522.5 100.1%  
Effective tax rate %37.627.2 138.4%   
Net profit margin %13.711.3 121.6%  
BALANCE SHEET DATA
Current assets Rs m15,92252,623 30.3%   
Current liabilities Rs m6,23552,022 12.0%   
Net working cap to sales %35.01.0 3,488.6%  
Current ratio x2.61.0 252.4%  
Inventory Days Days64120 53.2%  
Debtors Days Days2176 27.4%  
Net fixed assets Rs m7,53985,016 8.9%   
Share capital Rs m230846 27.2%   
"Free" reserves Rs m21,96245,376 48.4%   
Net worth Rs m22,19246,222 48.0%   
Long term debt Rs m041,115 0.0%   
Total assets Rs m29,839142,432 20.9%  
Interest coverage x872.14.0 21,705.6%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.90.4 220.4%   
Return on assets %12.86.9 184.5%  
Return on equity %17.214.7 116.9%  
Return on capital %27.514.2 193.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,58714,580 52.0%   
Fx outflow Rs m7,1453,600 198.5%   
Net fx Rs m44210,980 4.0%   
CASH FLOW
From Operations Rs m3,7398,942 41.8%  
From Investments Rs m-731-47,070 1.6%  
From Financial Activity Rs m-1,97234,174 -5.8%  
Net Cashflow Rs m1,036-3,655 -28.3%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.0 205.1%  
FIIs % 14.6 12.6 115.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 8.8 119.3%  
Shareholders   15,184 26,511 57.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALEMBIC PHARMA  ELDER PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens on a Strong Note Tracking Global Cues; Metal & Realty Stocks Lead(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.7% while the Hang Seng is up 2.4%.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 166.7% (Quarterly Result Update)

May 22, 2019 | Updated on May 22, 2019

For the quarter ended March 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 166.7% YoY). Sales on the other hand came in at Rs 19 bn (up 7.8% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 324.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended December 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 324.1% YoY). Sales on the other hand came in at Rs 21 bn (up 38.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 19, 2019 10:29 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - AJANTA PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS